RVTY — Revvity, Inc. | SharesGrow.com

Revvity, Inc. (RVTY) 是一家 Medical - Diagnostics & Research 公司，屬於醫療保健產業, 目前交易價格為 $93.51. 其SharesGrow評分為 56/100, 表明高於平均的投資特徵， 7項中通過2項.

SharesGrow calculates the intrinsic value of RVTY = $66.26 (-29.1% 相對於當前價格, 該股票看起來被高估). 分析師共識目標價為 RVTY = $115 (+23.1% 上漲空間).

估值: RVTY 本益比(P/E)為 41.4 (S&P 500平均約25) 前瞻PEG為 3.84.

財務數據: 營收為 $2.9B, -4.4%/yr 平均成長. 淨利潤為 $242M, 成長率為 -16.6%/yr. 淨利潤率為 8.5% (較薄). 毛利率為 53.1% (-7 pp 趨勢).

資產負債表: 總債務為 $3.5B 對比 $7.3B 股東權益 (D/E比率 0.48, 保守). 流動比率為 1.68 (流動性強). 資產負債率為 28.9%. 總資產: $12.2B.

分析師展望: 17 / 29 位分析師評級 RVTY 為買入 (59%) — 適度共識.

SharesGrow 7項標準細分: Value 27/100 (Fail), Growth 15/100 (Fail), Past 100/100 (Pass), Health 83/100 (Pass), Moat 65/100 (Partial), Future 58/100 (Partial), Income 45/100 (Partial).

$115.14

▲ 23.13% 上漲空間

Average Price Target

基於 29 位華爾街分析師對 Revvity, Inc. 提供的12個月價格目標，平均目標價為 $115.14，最高預測為 $129.00，最低預測為 $105.00。

Highest Price Target

$129.00

Average Price Target

$115.14

Lowest Price Target

$105.00

RVTY SharesGrow 評分概覽

56/100

SharesGrow Score

Above average fundamentals

View full scorecard →

價值 27/100

估值 — P/E, PEG, Forward PEG

成長 15/100

財務數據 — 平均成長

過去 100/100

強勁 — 趨勢

健康 83/100

資產負債表 — D/E比率, 流動比率為

護城河 65/100

毛利率為 + market cap

未來 58/100

分析師展望 — 為買入

收入 45/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — RVTY

✗

價值 Fail

27/100

RVTY 本益比(P/E)為 41.4 (S&P 500平均約25). Forward PEG 3.84 — 被高估. Trailing PEG 9.15. 分析師共識目標價為 $115, 意味著 +23% 相對於當前價格 $94. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

RVTY: -4.4%/yr 營收為, -16.6%/yr 淨利潤為平均成長. 較弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

RVTY: 4 / 4 年獲利. 強勁 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

資產負債表 RVTY: D/E比率 0.48 (保守), 流動比率為 1.68 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

RVTY: 毛利率為 53.1% (-7 pp 趨勢), $10B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 65/100. ≥ 70 = Pass.

分析師展望: 17 / 29 位分析師評級 RVTY 為買入 (59%). 分析師共識目標價為 $115 (+23% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

RVTY: 淨利潤率為 8.5%. 較薄 (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

市場數據

52週區間81.36-118.3

成交量559.52K

30日平均成交量1.26M

市值$10.45B

Beta（1年）1.13

股息率$0.2800

Share Statistics

EPS（TTM）2.08

流通股數$113.21M

IPO Date1965-07-06

Employees11,000

CEOPrahlad R. Singh

Financial Highlights & Ratios

Revenue (TTM)$2.86B

Gross Profit$1.52B

EBITDA$662.72M

Net Income$241.68M

Operating Income$356.64M

Total Cash$919.87M

Total Debt$3.52B

Net Debt$2.6B

Total Assets$12.17B

Price / Earnings (P/E)45

Price / Sales (P/S)3.66

Analyst Forecast

1Y Price Target$118.00

Target High$129.00

Target Low$105.00

上漲空間+26.2%

評級共識Buy

覆蓋分析師數29

買入 59% 持有 41% 賣出 0%

Price Target Summary

公司資訊

國家US

交易所NYSE

貨幣USD

ISINUS7140461093

股價走勢

RVTY

Revvity, Inc. ↗ · NYSE

Healthcare • Medical - Diagnostics & Research

81.36 52WK RANGE 118.30

其他人也在看

IDXX

IDEXX Laboratories, Inc.

$584.05

+1.75%

A

Agilent Technologies, Inc.

Mettler-Toledo International Inc.

$1,341.53

-0.32%

LH

Laboratory Corporation of America Holdings

$268.87

+1.78%

EXAS

Exact Sciences Corporation

Medpace Holdings, Inc.

$520.00

+3.74%

Revvity, Inc. RVTY NYSE

RVTY SharesGrow 評分概覽

評分明細 — RVTY

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒